Unlike the patient cohort in a prior study conducted in China (Liao et al., 2022), our cohort of ALS patients harboring KIF1A missense mutations did not exhibit obvious sensory impairment, highlighting the high clinical heterogeneity of ALS patients harboring KIF1A variants. Here, KIF1A is linked to amyotrophic lateral sclerosis.